Germany: Astorg acquires CordenPharma from ICIG

Paris based European private equity firm, Astorg, is acquiring CordenPharma a global pharmaceutical CDMO, from International Chemical Investors Group (ICIG). As part of the transaction, the founders will take the opportunity to reinvest as partners with Astorg. Germany based CordenPharma is growing quickly thanks to a position in complex and fast-growing drug modalities including mRNA…

You must be a HMI Subscriber to view this content.

Subscribe Now »